Chemoinformaics analysis of 2-Amino-5-hydroxyhexanoic acid
| Molecular Weight | 147.174 | nRot | 4 |
| Heavy Atom Molecular Weight | 134.07 | nRig | 1 |
| Exact Molecular Weight | 147.09 | nRing | 0 |
| Solubility: LogS | -0.351 | nHRing | 0 |
| Solubility: LogP | -2.942 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 22.1943 |
| nHD | 3 | BPOL | 13.3397 |
| QED | 0.503 |
| Synth | 3.028 |
| Natural Product Likeliness | 1.621 |
| NR-PPAR-gamma | 0.01 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.11 |
| HIA | 0.061 |
| CACO-2 | -5.917 |
| MDCK | 0.00792808 |
| BBB | 0.677 |
| PPB | 0.0767566 |
| VDSS | 0.497 |
| FU | 0.907149 |
| CYP1A2-inh | 0.013 |
| CYP1A2-sub | 0.049 |
| CYP2c19-inh | 0.049 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.017 |
| CYP2c9-sub | 0.4 |
| CYP2d6-inh | 0.032 |
| CYP2d6-sub | 0.222 |
| CYP3a4-inh | 0.01 |
| CYP3a4-sub | 0.039 |
| CL | 7.959 |
| T12 | 0.613 |
| hERG | 0.019 |
| Ames | 0.023 |
| ROA | 0.023 |
| SkinSen | 0.172 |
| Carcinogencity | 0.039 |
| EI | 0.088 |
| Respiratory | 0.171 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.968021 |